Merged Novartis and AstraZeneca Unit to Buy NADII to Lead Bioinformatics Effort | GenomeWeb

SYNGENTA, the new company that will be formed once Novartis and AstraZeneca complete their plans to merge agricultural units, is expected to purchase the Novartis Agricultural Discovery Institute from the Novartis Research Foundation, Steven Briggs, president and CEO of the institute said.

NADII, a genomics research center dedicated to agriculture, will handle much of Syngenta’s bioinformatics and genomics work.

The Novartis Research Foundation was established and founded by Novartis, but is now an independent organization.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.